|
|
.
See Category: Endocrine, nutritional and metabolic diseases
ICD-10 (CM) Code and Descriptor
|
E06.4 |
Drug-induced thyroiditis
|
E064 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 14.33%
|
22.20%
|
27.28%
|
15.65%
|
8.08%
|
4.18%
|
2.40%
|
1.76%
|
1.10%
|
0.64%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for E06.4*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
84443
|
ASSAY THYROID STIM HORMONE |
659
|
659
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
517
|
522
|
|
84439
|
ASSAY OF FREE THYROXINE |
496
|
496
|
|
80053
|
COMPREHEN METABOLIC PANEL |
325
|
325
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
315
|
315
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
218
|
220
|
|
84481
|
FREE ASSAY (FT-3) |
161
|
161
|
|
84480
|
ASSAY TRIIODOTHYRONINE (T3) |
121
|
121
|
|
96413
|
CHEMO IV INFUSION 1 HR |
65
|
65
|
|
80048
|
METABOLIC PANEL TOTAL CA |
48
|
48
|
|
82533
|
TOTAL CORTISOL |
43
|
43
|
|
80061
|
LIPID PANEL |
43
|
43
|
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
43
|
43
|
|
80076
|
HEPATIC FUNCTION PANEL |
40
|
40
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
38
|
38
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
38
|
2,010
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
36
|
36
|
|
84436
|
ASSAY OF TOTAL THYROXINE |
35
|
35
|
|
83735
|
ASSAY OF MAGNESIUM |
35
|
35
|
|
J9271
|
INJ PEMBROLIZUMAB |
31
|
6,600
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
E06.4 related to the following DRG Codes:
011-013
643-645
|
